1	3	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Discussion	_	_	NN	_	_	_	_	_


1	Genome-wide	_	_	JJ	_	_	_	_	_
2	DNA	_	_	NN	_	_	_	_	_
3	methylation	_	_	NN	_	_	_	_	_
4	patterns	_	_	NNS	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	methylation	_	_	NN	_	_	_	_	_
7	abnormalities	_	_	NNS	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	pituitary	_	_	JJ	_	_	_	_	_
10	tumors	_	_	NNS	_	_	_	_	_
11	have	_	_	VBP	_	_	_	_	_
12	been	_	_	VBN	_	_	_	_	_
13	reported	_	_	VBN	_	_	_	_	_
14	previously	_	_	RB	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	date	_	_	VB	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	however	_	_	RB	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	impact	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	aberrant	_	_	JJ	_	_	_	_	_
10	CpG	_	_	NN	_	_	_	_	_
11	methylation	_	_	NN	_	_	_	_	_
12	on	_	_	IN	_	_	_	_	_
13	gene	_	_	NN	_	_	_	_	_
14	expression	_	_	NN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	NFPAs	_	_	NNP	_	_	_	_	_
17	has	_	_	VBZ	_	_	_	_	_
18	not	_	_	RB	_	_	_	_	_
19	been	_	_	VBN	_	_	_	_	_
20	investigated	_	_	VBN	_	_	_	_	_
21	by	_	_	IN	_	_	_	_	_
22	a	_	_	DT	_	_	_	_	_
23	multi-omics	_	_	NNS	_	_	_	_	_
24	approach	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	we	_	_	PRP	_	_	_	_	_
6	combined	_	_	VBD	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	results	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	methylome	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	transcriptome	_	_	NN	_	_	_	_	_
13	profiling	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	33	_	_	CD	_	_	_	_	_
16	gonadotroph	_	_	NN	_	_	_	_	_
17	NFPA	_	_	NNP	_	_	_	_	_
18	samples	_	_	NNS	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	investigate	_	_	VB	_	_	_	_	_
21	whether	_	_	IN	_	_	_	_	_
22	DNA	_	_	NN	_	_	_	_	_
23	methylation	_	_	NN	_	_	_	_	_
24	at	_	_	IN	_	_	_	_	_
25	particular	_	_	JJ	_	_	_	_	_
26	CpGs	_	_	NNS	_	_	_	_	_
27	that	_	_	WDT	_	_	_	_	_
28	are	_	_	VBP	_	_	_	_	_
29	aberrantly	_	_	RB	_	_	_	_	_
30	methylated	_	_	VBN	_	_	_	_	_
31	in	_	_	IN	_	_	_	_	_
32	gonadotroph	_	_	NN	_	_	_	_	_
33	tumors	_	_	NNS	_	_	_	_	_
34	correlates	_	_	VBZ	_	_	_	_	_
35	with	_	_	IN	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	expression	_	_	NN	_	_	_	_	_
38	levels	_	_	NNS	_	_	_	_	_
39	of	_	_	IN	_	_	_	_	_
40	the	_	_	DT	_	_	_	_	_
41	corresponding	_	_	JJ	_	_	_	_	_
42	genes	_	_	NNS	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	Gonadotroph	_	_	NNP	_	_	_	_	_
2	NFPAs	_	_	NNP	_	_	_	_	_
3	exhibited	_	_	VBD	_	_	_	_	_
4	an	_	_	DT	_	_	_	_	_
5	increase	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	DNA	_	_	NN	_	_	_	_	_
8	methylation	_	_	NN	_	_	_	_	_
9	relative	_	_	JJ	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	normal	_	_	JJ	_	_	_	_	_
12	pituitary	_	_	JJ	_	_	_	_	_
13	sections	_	_	NNS	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	large	_	_	JJ	_	_	_	_	_
18	number	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	differentially	_	_	RB	_	_	_	_	_
21	methylated	_	_	JJ	_	_	_	_	_
22	CpGs	_	_	NNS	_	_	_	_	_
23	have	_	_	VBP	_	_	_	_	_
24	been	_	_	VBN	_	_	_	_	_
25	identified	_	_	VBN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	our	_	_	PRP$	_	_	_	_	_
3	analysis	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	approximately	_	_	RB	_	_	_	_	_
6	85	_	_	CD	_	_	_	_	_
7	%	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	CpGs	_	_	NNS	_	_	_	_	_
10	that	_	_	WDT	_	_	_	_	_
11	are	_	_	VBP	_	_	_	_	_
12	differentially	_	_	RB	_	_	_	_	_
13	methylated	_	_	VBN	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	NFPAs	_	_	NNP	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	associated	_	_	VBN	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	known	_	_	VBN	_	_	_	_	_
20	human	_	_	JJ	_	_	_	_	_
21	genes	_	_	NNS	_	_	_	_	_
22	were	_	_	VBD	_	_	_	_	_
23	hypermethylated	_	_	VBN	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	tumors	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Our	_	_	PRP$	_	_	_	_	_
2	correlation-based	_	_	JJ	_	_	_	_	_
3	analysis	_	_	NN	_	_	_	_	_
4	revealed	_	_	VBD	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	methylation	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	major	_	_	JJ	_	_	_	_	_
10	fraction	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	CpGs	_	_	NNS	_	_	_	_	_
13	that	_	_	WDT	_	_	_	_	_
14	are	_	_	VBP	_	_	_	_	_
15	differentially	_	_	RB	_	_	_	_	_
16	methylated	_	_	VBN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	gonadotroph	_	_	NN	_	_	_	_	_
19	adenomas	_	_	NNS	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	pituitary	_	_	JJ	_	_	_	_	_
22	sections	_	_	NNS	_	_	_	_	_
23	did	_	_	VBD	_	_	_	_	_
24	not	_	_	RB	_	_	_	_	_
25	correlate	_	_	VB	_	_	_	_	_
26	with	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	expression	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	annotated	_	_	VBN	_	_	_	_	_
32	genes	_	_	NNS	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	been	_	_	VBN	_	_	_	_	_
5	observed	_	_	VBN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	similar	_	_	JJ	_	_	_	_	_
9	analysis	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	other	_	_	JJ	_	_	_	_	_
12	human	_	_	JJ	_	_	_	_	_
13	cancers	_	_	NNS	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	observed	_	_	VBD	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	correlation	_	_	NN	_	_	_	_	_
5	between	_	_	IN	_	_	_	_	_
6	DNA	_	_	NN	_	_	_	_	_
7	methylation	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	gene	_	_	NN	_	_	_	_	_
10	expression	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	approximately	_	_	RB	_	_	_	_	_
13	11	_	_	CD	_	_	_	_	_
14	%	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	gene-associated	_	_	JJ	_	_	_	_	_
17	CpGs	_	_	NNS	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	aberrant	_	_	JJ	_	_	_	_	_
20	DNA	_	_	NN	_	_	_	_	_
21	methylation	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	CpG	_	_	NNP	_	_	_	_	_
3	sites	_	_	NNS	_	_	_	_	_
4	are	_	_	VBP	_	_	_	_	_
5	located	_	_	VBN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	or	_	_	CC	_	_	_	_	_
8	near	_	_	IN	_	_	_	_	_
9	genes	_	_	NNS	_	_	_	_	_
10	for	_	_	IN	_	_	_	_	_
11	which	_	_	WDT	_	_	_	_	_
12	methylation	_	_	NN	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	expression	_	_	NN	_	_	_	_	_
15	were	_	_	VBD	_	_	_	_	_
16	previously	_	_	RB	_	_	_	_	_
17	reported	_	_	VBN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	be	_	_	VB	_	_	_	_	_
20	correlated	_	_	VBN	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	pituitary	_	_	JJ	_	_	_	_	_
23	adenomas	_	_	NNS	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	including	_	_	VBG	_	_	_	_	_
26	STAT5A	_	_	NN	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	RHOD	_	_	NN	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	GALNT9	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	RASSF1	_	_	NNP	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	as	_	_	RB	_	_	_	_	_
36	well	_	_	RB	_	_	_	_	_
37	as	_	_	IN	_	_	_	_	_
38	genes	_	_	NNS	_	_	_	_	_
39	with	_	_	IN	_	_	_	_	_
40	previously	_	_	RB	_	_	_	_	_
41	described	_	_	VBN	_	_	_	_	_
42	aberrant	_	_	JJ	_	_	_	_	_
43	methylation	_	_	NN	_	_	_	_	_
44	in	_	_	IN	_	_	_	_	_
45	pituitary	_	_	JJ	_	_	_	_	_
46	tumors	_	_	NNS	_	_	_	_	_
47	,	_	_	,	_	_	_	_	_
48	including	_	_	VBG	_	_	_	_	_
49	CDKN1A	_	_	NN	_	_	_	_	_
50	,	_	_	,	_	_	_	_	_
51	TP73	_	_	NNP	_	_	_	_	_
52	,	_	_	,	_	_	_	_	_
53	and	_	_	CC	_	_	_	_	_
54	STAT3	_	_	NNP	_	_	_	_	_
55	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	correlation	_	_	NN	_	_	_	_	_
3	between	_	_	IN	_	_	_	_	_
4	aberrant	_	_	JJ	_	_	_	_	_
5	DNA	_	_	NN	_	_	_	_	_
6	methylation	_	_	NN	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	expression	_	_	NN	_	_	_	_	_
10	level	_	_	NN	_	_	_	_	_
11	was	_	_	VBD	_	_	_	_	_
12	also	_	_	RB	_	_	_	_	_
13	observed	_	_	VBN	_	_	_	_	_
14	for	_	_	IN	_	_	_	_	_
15	HMGA2	_	_	NNP	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	which	_	_	WDT	_	_	_	_	_
18	plays	_	_	VBZ	_	_	_	_	_
19	an	_	_	DT	_	_	_	_	_
20	important	_	_	JJ	_	_	_	_	_
21	role	_	_	NN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	pathogenesis	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	pituitary	_	_	JJ	_	_	_	_	_
27	tumors	_	_	NNS	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	GSEA	_	_	NNP	_	_	_	_	_
2	revealed	_	_	VBD	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	genes	_	_	NNS	_	_	_	_	_
5	whose	_	_	WP$	_	_	_	_	_
6	expression	_	_	NN	_	_	_	_	_
7	was	_	_	VBD	_	_	_	_	_
8	related	_	_	VBN	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	methylation	_	_	NN	_	_	_	_	_
12	level	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	differentially	_	_	RB	_	_	_	_	_
15	methylated	_	_	VBN	_	_	_	_	_
16	CpGs	_	_	NNS	_	_	_	_	_
17	were	_	_	VBD	_	_	_	_	_
18	enriched	_	_	VBN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	pathways	_	_	NNS	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	processes	_	_	NNS	_	_	_	_	_
23	important	_	_	JJ	_	_	_	_	_
24	for	_	_	IN	_	_	_	_	_
25	tumor	_	_	NN	_	_	_	_	_
26	development	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	most	_	_	JJS	_	_	_	_	_
3	CpGs	_	_	NNS	_	_	_	_	_
4	whose	_	_	WP$	_	_	_	_	_
5	methylation	_	_	NN	_	_	_	_	_
6	was	_	_	VBD	_	_	_	_	_
7	related	_	_	VBN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	gene	_	_	NN	_	_	_	_	_
10	expression	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	relationship	_	_	NN	_	_	_	_	_
14	was	_	_	VBD	_	_	_	_	_
15	an	_	_	DT	_	_	_	_	_
16	inverse	_	_	JJ	_	_	_	_	_
17	one	_	_	CD	_	_	_	_	_
18	:	_	_	:	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	sites	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	hypermethylation	_	_	NN	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	hypomethylation	_	_	NN	_	_	_	_	_
8	corresponded	_	_	VBD	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	decrease	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	increase	_	_	NN	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	gene	_	_	NN	_	_	_	_	_
16	expression	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	respectively	_	_	RB	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	results	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	generally	_	_	RB	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	line	_	_	NN	_	_	_	_	_
7	with	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	idea	_	_	NN	_	_	_	_	_
10	that	_	_	IN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	tumors	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	elevated	_	_	VBN	_	_	_	_	_
15	methylation	_	_	NN	_	_	_	_	_
16	is	_	_	VBZ	_	_	_	_	_
17	associated	_	_	VBN	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	transcriptional	_	_	JJ	_	_	_	_	_
20	silencing	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	providing	_	_	VBG	_	_	_	_	_
23	a	_	_	DT	_	_	_	_	_
24	mechanism	_	_	NN	_	_	_	_	_
25	for	_	_	IN	_	_	_	_	_
26	inactivation	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	genes	_	_	NNS	_	_	_	_	_
29	with	_	_	IN	_	_	_	_	_
30	tumor-suppressor	_	_	NN	_	_	_	_	_
31	function	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	On	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	other	_	_	JJ	_	_	_	_	_
4	hand	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	hypomethylation	_	_	NN	_	_	_	_	_
7	may	_	_	MD	_	_	_	_	_
8	result	_	_	VB	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	activation	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	potential	_	_	JJ	_	_	_	_	_
14	oncogenes	_	_	NNS	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	simplify	_	_	VB	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	interpretation	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	results	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	we	_	_	PRP	_	_	_	_	_
10	distinguished	_	_	VBD	_	_	_	_	_
11	two	_	_	CD	_	_	_	_	_
12	classes	_	_	NNS	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	aberrantly	_	_	RB	_	_	_	_	_
15	methylated	_	_	VBN	_	_	_	_	_
16	CpGs	_	_	NNS	_	_	_	_	_
17	:	_	_	:	_	_	_	_	_
18	Those	_	_	DT	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	promoters	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	i.	_	_	FW	_	_	_	_	_
23	e.	_	_	FW	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	located	_	_	VBN	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	5	_	_	CD	_	_	_	_	_
29	’	_	_	POS	_	_	_	_	_
30	promoter	_	_	NN	_	_	_	_	_
31	gene	_	_	NN	_	_	_	_	_
32	region	_	_	NN	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	which	_	_	WDT	_	_	_	_	_
35	includes	_	_	VBZ	_	_	_	_	_
36	regions	_	_	NNS	_	_	_	_	_
37	from	_	_	IN	_	_	_	_	_
38	1500	_	_	CD	_	_	_	_	_
39	bp	_	_	NN	_	_	_	_	_
40	upstream	_	_	NN	_	_	_	_	_
41	of	_	_	IN	_	_	_	_	_
42	the	_	_	DT	_	_	_	_	_
43	TSS	_	_	NN	_	_	_	_	_
44	up	_	_	IN	_	_	_	_	_
45	to	_	_	TO	_	_	_	_	_
46	the	_	_	DT	_	_	_	_	_
47	first	_	_	JJ	_	_	_	_	_
48	exon	_	_	NN	_	_	_	_	_
49	of	_	_	IN	_	_	_	_	_
50	the	_	_	DT	_	_	_	_	_
51	gene	_	_	NN	_	_	_	_	_
52	,	_	_	,	_	_	_	_	_
53	and	_	_	CC	_	_	_	_	_
54	those	_	_	DT	_	_	_	_	_
55	in	_	_	IN	_	_	_	_	_
56	gene	_	_	NN	_	_	_	_	_
57	bodies	_	_	NNS	_	_	_	_	_
58	,	_	_	,	_	_	_	_	_
59	including	_	_	VBG	_	_	_	_	_
60	exons	_	_	NNS	_	_	_	_	_
61	,	_	_	,	_	_	_	_	_
62	introns	_	_	NNS	_	_	_	_	_
63	,	_	_	,	_	_	_	_	_
64	and	_	_	CC	_	_	_	_	_
65	3’UTR	_	_	NN	_	_	_	_	_
66	sequences	_	_	NNS	_	_	_	_	_
67	.	_	_	.	_	_	_	_	_
68	For	_	_	IN	_	_	_	_	_
69	81	_	_	CD	_	_	_	_	_
70	%	_	_	NN	_	_	_	_	_
71	of	_	_	IN	_	_	_	_	_
72	the	_	_	DT	_	_	_	_	_
73	CpGs	_	_	NNS	_	_	_	_	_
74	located	_	_	VBN	_	_	_	_	_
75	in	_	_	IN	_	_	_	_	_
76	promoters	_	_	NNS	_	_	_	_	_
77	for	_	_	IN	_	_	_	_	_
78	which	_	_	WDT	_	_	_	_	_
79	methylation	_	_	NN	_	_	_	_	_
80	and	_	_	CC	_	_	_	_	_
81	expression	_	_	NN	_	_	_	_	_
82	were	_	_	VBD	_	_	_	_	_
83	correlated	_	_	VBN	_	_	_	_	_
84	,	_	_	,	_	_	_	_	_
85	the	_	_	DT	_	_	_	_	_
86	correlation	_	_	NN	_	_	_	_	_
87	was	_	_	VBD	_	_	_	_	_
88	negative	_	_	JJ	_	_	_	_	_
89	,	_	_	,	_	_	_	_	_
90	in	_	_	IN	_	_	_	_	_
91	concordance	_	_	NN	_	_	_	_	_
92	with	_	_	IN	_	_	_	_	_
93	the	_	_	DT	_	_	_	_	_
94	overall	_	_	JJ	_	_	_	_	_
95	model	_	_	NN	_	_	_	_	_
96	.	_	_	.	_	_	_	_	_


1	Approximately	_	_	RB	_	_	_	_	_
2	one-third	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	all	_	_	DT	_	_	_	_	_
5	methylation/expression-correlated	_	_	JJ	_	_	_	_	_


1	CpGs	_	_	NNS	_	_	_	_	_
2	were	_	_	VBD	_	_	_	_	_
3	positively	_	_	RB	_	_	_	_	_
4	correlated	_	_	VBN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	i.	_	_	FW	_	_	_	_	_
7	e.	_	_	FW	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	hypermethylation	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	hypomethylation	_	_	NN	_	_	_	_	_
12	were	_	_	VBD	_	_	_	_	_
13	associated	_	_	VBN	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	increased	_	_	VBN	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	decreased	_	_	VBN	_	_	_	_	_
18	expression	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	respectively	_	_	RB	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	Among	_	_	IN	_	_	_	_	_
2	these	_	_	DT	_	_	_	_	_
3	CpGs	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	most	_	_	JJS	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	located	_	_	VBN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	gene	_	_	NN	_	_	_	_	_
10	bodies	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	whereas	_	_	IN	_	_	_	_	_
13	only	_	_	RB	_	_	_	_	_
14	22	_	_	CD	_	_	_	_	_
15	%	_	_	NN	_	_	_	_	_
16	are	_	_	VBP	_	_	_	_	_
17	located	_	_	VBN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	promoters	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	consistent	_	_	JJ	_	_	_	_	_
22	with	_	_	IN	_	_	_	_	_
23	previously	_	_	RB	_	_	_	_	_
24	published	_	_	VBN	_	_	_	_	_
25	reports	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Gene	_	_	NN	_	_	_	_	_
2	body	_	_	NN	_	_	_	_	_
3	methylation	_	_	NN	_	_	_	_	_
4	has	_	_	VBZ	_	_	_	_	_
5	been	_	_	VBN	_	_	_	_	_
6	observed	_	_	VBN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	active	_	_	JJ	_	_	_	_	_
9	genes	_	_	NNS	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	implying	_	_	VBG	_	_	_	_	_
12	that	_	_	IN	_	_	_	_	_
13	it	_	_	PRP	_	_	_	_	_
14	may	_	_	MD	_	_	_	_	_
15	have	_	_	VB	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	opposite	_	_	JJ	_	_	_	_	_
18	effect	_	_	NN	_	_	_	_	_
19	on	_	_	IN	_	_	_	_	_
20	gene	_	_	NN	_	_	_	_	_
21	expression	_	_	NN	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	promoter	_	_	NN	_	_	_	_	_
24	methylation	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	i.	_	_	FW	_	_	_	_	_
27	e.	_	_	FW	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	increased	_	_	VBN	_	_	_	_	_
30	DNA	_	_	NN	_	_	_	_	_
31	methylation	_	_	NN	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	gene	_	_	NN	_	_	_	_	_
34	bodies	_	_	NNS	_	_	_	_	_
35	may	_	_	MD	_	_	_	_	_
36	promote	_	_	VB	_	_	_	_	_
37	transcription	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	we	_	_	PRP	_	_	_	_	_
6	compared	_	_	VBD	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	expression	_	_	NN	_	_	_	_	_
9	profiles	_	_	NNS	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	NFPAs	_	_	NNP	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	normal	_	_	JJ	_	_	_	_	_
14	pituitary	_	_	JJ	_	_	_	_	_
15	sections	_	_	NNS	_	_	_	_	_
16	without	_	_	IN	_	_	_	_	_
17	evidence	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	neoplastic	_	_	JJ	_	_	_	_	_
20	features	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	obtained	_	_	VBN	_	_	_	_	_
23	by	_	_	IN	_	_	_	_	_
24	Rathke	_	_	NNP	_	_	_	_	_
25	’s	_	_	POS	_	_	_	_	_
26	cleft	_	_	NN	_	_	_	_	_
27	cyst	_	_	NN	_	_	_	_	_
28	surgery	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	allowed	_	_	VBD	_	_	_	_	_
3	us	_	_	PRP	_	_	_	_	_
4	to	_	_	TO	_	_	_	_	_
5	identify	_	_	VB	_	_	_	_	_
6	DEGs	_	_	NNS	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	investigate	_	_	VB	_	_	_	_	_
9	which	_	_	WDT	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	these	_	_	DT	_	_	_	_	_
12	genes	_	_	NNS	_	_	_	_	_
13	exhibits	_	_	VBZ	_	_	_	_	_
14	methylation-dependent	_	_	JJ	_	_	_	_	_
15	expression	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	When	_	_	WRB	_	_	_	_	_
2	we	_	_	PRP	_	_	_	_	_
3	compared	_	_	VBD	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	list	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	genes	_	_	NNS	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	methylation/expression	_	_	NN	_	_	_	_	_
10	correlation	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	list	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	DEGs	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	most	_	_	JJS	_	_	_	_	_
18	genes	_	_	NNS	_	_	_	_	_
19	were	_	_	VBD	_	_	_	_	_
20	hypermethylated	_	_	VBN	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	a	_	_	DT	_	_	_	_	_
23	fold	_	_	NN	_	_	_	_	_
24	change	_	_	NN	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	expression	_	_	NN	_	_	_	_	_
27	corresponding	_	_	VBG	_	_	_	_	_
28	to	_	_	TO	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	sign	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	correlation	_	_	NN	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	e.	_	_	FW	_	_	_	_	_
36	g.	_	_	FW	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	a	_	_	DT	_	_	_	_	_
39	gene	_	_	NN	_	_	_	_	_
40	with	_	_	IN	_	_	_	_	_
41	negative	_	_	JJ	_	_	_	_	_
42	methylation/expression	_	_	NN	_	_	_	_	_
43	correlation	_	_	NN	_	_	_	_	_
44	that	_	_	WDT	_	_	_	_	_
45	was	_	_	VBD	_	_	_	_	_
46	hypermethylated	_	_	VBN	_	_	_	_	_
47	and	_	_	CC	_	_	_	_	_
48	downregulated	_	_	VBN	_	_	_	_	_
49	in	_	_	IN	_	_	_	_	_
50	tumors	_	_	NNS	_	_	_	_	_
51	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	subset	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	genes	_	_	NNS	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	however	_	_	RB	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	fold	_	_	NN	_	_	_	_	_
11	change	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	expression	_	_	NN	_	_	_	_	_
14	was	_	_	VBD	_	_	_	_	_
15	inconsistent	_	_	JJ	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	difference	_	_	NN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	DNA	_	_	NN	_	_	_	_	_
21	methylation	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	sign	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	correlation	_	_	NN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	e.	_	_	FW	_	_	_	_	_
30	g.	_	_	FW	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	a	_	_	DT	_	_	_	_	_
33	hypermethylated	_	_	VBN	_	_	_	_	_
34	gene	_	_	NN	_	_	_	_	_
35	with	_	_	IN	_	_	_	_	_
36	negative	_	_	JJ	_	_	_	_	_
37	methylation/expression	_	_	NN	_	_	_	_	_
38	correlation	_	_	NN	_	_	_	_	_
39	that	_	_	WDT	_	_	_	_	_
40	was	_	_	VBD	_	_	_	_	_
41	upregulated	_	_	VBN	_	_	_	_	_
42	in	_	_	IN	_	_	_	_	_
43	tumors	_	_	NNS	_	_	_	_	_
44	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	genes	_	_	NNS	_	_	_	_	_
3	were	_	_	VBD	_	_	_	_	_
4	excluded	_	_	VBN	_	_	_	_	_
5	from	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	functional	_	_	JJ	_	_	_	_	_
8	GSEA	_	_	NNP	_	_	_	_	_
9	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	believe	_	_	VBP	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	differential	_	_	NN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	expression	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	these	_	_	DT	_	_	_	_	_
10	genes	_	_	NNS	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	NFPAs	_	_	NNP	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	pituitary	_	_	JJ	_	_	_	_	_
15	tissue	_	_	NN	_	_	_	_	_
16	was	_	_	VBD	_	_	_	_	_
17	due	_	_	JJ	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	mechanism	_	_	NN	_	_	_	_	_
21	distinct	_	_	JJ	_	_	_	_	_
22	from	_	_	IN	_	_	_	_	_
23	aberrant	_	_	JJ	_	_	_	_	_
24	DNA	_	_	NN	_	_	_	_	_
25	methylation	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	despite	_	_	IN	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	fact	_	_	NN	_	_	_	_	_
30	that	_	_	IN	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	expression	_	_	NN	_	_	_	_	_
33	levels	_	_	NNS	_	_	_	_	_
34	of	_	_	IN	_	_	_	_	_
35	these	_	_	DT	_	_	_	_	_
36	genes	_	_	NNS	_	_	_	_	_
37	were	_	_	VBD	_	_	_	_	_
38	methylation-related	_	_	JJ	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	general	_	_	JJ	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	our	_	_	PRP$	_	_	_	_	_
5	analysis	_	_	NN	_	_	_	_	_
6	showed	_	_	VBD	_	_	_	_	_
7	that	_	_	IN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	gonadotroph	_	_	NN	_	_	_	_	_
10	NFPAs	_	_	NNP	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	expression	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	9	_	_	CD	_	_	_	_	_
16	%	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	DEGs	_	_	NNS	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	correlated	_	_	VBN	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	aberrant	_	_	JJ	_	_	_	_	_
23	methylation	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_

